Skip to content
← Full study record

NCT01061606 · MORE INFO

Limitations, agreements, and source contact

Temsirolimus in Treating Patients With Recurrent or Persistent Cancer of the Uterus · Source last updated 2016-11-09

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
false
restriction Type
LTE60
restrictive Agreement
true
point Of Contact
email
lescobar@montefiore.org
organization
Montefiore Medical Center
phone
718-379-6866
title
Lisa Escobar-Peralta, Program Manager
Complete source fields
certain Agreement
pi Sponsor Employee
false
restriction Type
LTE60
restrictive Agreement
true
point Of Contact
email
lescobar@montefiore.org
organization
Montefiore Medical Center
phone
718-379-6866
title
Lisa Escobar-Peralta, Program Manager

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice